SCHEMBL21564604

SCHEMBL21564604

NCCCc1cn(-c2ccc(F)cc2)c(=O)c(N2CCCCC2)n1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
NPSR1 Q6W5P4 2/20 0.36
TP53 P04637 3/20 0.35
MAPT P10636 2/20 0.35
ALDH1A1 P00352 4/20 0.35
AR P10275 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
HSD17B10 Q99714 1/20 0.35
KDM4E B2RXH2 1/20 0.35
HPGD P15428 1/20 0.35
TSHR P16473 1/20 0.35
MAPK1 P28482 1/20 0.35
CASP1 P29466 1/20 0.35
CASP7 P55210 1/20 0.35
DRD2 P14416 1/20 0.34
DRD4 P21917 1/20 0.34
DRD3 P35462 1/20 0.34
PIM1 P11309 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21564837 0.89 HRH4 (0.40) NPC1RAB9ATP53ALDH1A1MEN1
SCHEMBL23258213 0.89 HRH4 (0.39) TP53ALDH1A1MEN1KMT2AHSD17B10
SCHEMBL21553144 0.88 NPC1 (0.39) NPC1RAB9ANPSR1TP53MAPT
SCHEMBL21553049 0.84 AR (0.37) NPC1RAB9ANPSR1TP53MAPT
SCHEMBL21552901 0.83 NPC1 (0.41) NPC1RAB9ANPSR1TP53MAPT
SCHEMBL21564515 0.81 GRIA1 (0.42) NPC1MAPTALDH1A1MEN1KMT2A
SCHEMBL21564780 0.78 GABRA2 (0.43) NPC1RAB9ANPSR1MAPTALDH1A1
SCHEMBL21553098 0.78 GFER (0.38) TP53MAPTALDH1A1MEN1KMT2A
SCHEMBL21564469 0.77 ALDH1A1 (0.43) TP53MAPTALDH1A1MEN1KMT2A
SCHEMBL21564491 0.77 MEN1 (0.42) NPC1RAB9ATP53ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019217972-A1 KDM1A INHIBITORS FOR THE TREATMENT OF DISEASE IMAGO BIOSCIENCES, INC. (US) 2019-11-14 WO disclosed